Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short‐term results
Therapeutic effect
DOI:
10.1111/hepr.12527
Publication Date:
2015-05-14T04:05:04Z
AUTHORS (15)
ABSTRACT
The goal of the study was to evaluate efficacy and safety balloon-occluded transarterial chemoembolization (B-TACE) hepatocellular carcinoma (HCC) using miriplatin (a lipophilic anticancer drug) gelatin particles.B-TACE performed for 62 HCC nodules in 33 patients who could not be treated by surgical resection or radiofrequency ablation. All had a history (TACE) treatment prior B-TACE. As historical comparison, we investigated 40 28 TACE conventional microcatheter (C-TACE), particles. therapeutic effect per tumor compared between groups based on Response Evaluation Criteria Cancer Study Group Japan (RECICL) side-effects were Common Terminology Adverse Events (ver. 4.0).The after 4-12 weeks evaluated 59 B-TACE group 37 C-TACE group. Of these nodules, TE4 occurred 29 (49.2%) 10 (27%) Local significantly higher than C-TACE. hepatic function similar two groups.Our results suggest that with is useful carcinoma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (32)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....